Stockreport

Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16% [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF 50% of the business is held by the top 5 shareholders Using data from analyst forecasts alongside ownership research, one can better assess the future performance of [Read more]